Cision PR Newswire

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk...

enreap Earns 2025 Great Place To Work Certification™

PUNE, India, Feb. 13, 2025 /PRNewswire/ -- enreap is proud to be Certified™ by Great Place To Work® for the third year in a row....

WEL Networks Selects IFS’s AIP platform Copperleaf to Enhance Asset Investment Planning

VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- IFS, the leading provider of enterprise cloud and Industrial AI software, announces that WEL Networks, a leading...

‘Tianjin Port Impression’ experience hall opens: A fusion of culture, tourism and commerce

BEIJING, Feb. 13, 2025 /PRNewswire/ -- A news report from China Daily: Visitors in the immersive...

OneConnect Integrates DeepSeek into AI Agent Platform

SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- OneConnect Financial Technology Co., Ltd ("OneConnect" or the "Company", NYSE: OCFT, HKSE: 6638), a business technology service provider...